Bologna-based Cellply secures €3.6 million setting sights on future growth

Published on September 29, 2023

The Bolognese biotech startup, Cellply, has raised €3.6 million in a recent funding round. The main investors were Recomec, managed by the Zanelli family, LIFTT, and Schia Ventures. It’s worth noting that LIFTT and Schia Ventures have invested in Cellply before, showing their ongoing support for the company. Yet, in the constantly evolving realm of…

This content is for members only. Visit the site and log in/register to read.

The post Bologna-based Cellply secures €3.6 million setting sights on future growth appeared first on EU-Startups.

Continue reading on website
Other news

Berlin-based Blacklane has partnered with SIXT securing over €33.9 million in funding

September 29, 2023
Blacklane, a global chauffeur service, has announced a partnership with international auto-service provider, SIXT. This collaboration not only signifies a joint venture but also encompasses a considerable multi-million euro investment by SIXT, amounting to over €33.9 million, marking Blacklane’s second closing in its Series F funding round. With this move, SIXT joins the roster of… This content is

Debiopharm Innovation Fund: A €141+ million initiative to transform pharma R&D and cancer care innovation

September 29, 2023
Based in Lausanne, Switzerland, the Debiopharm Innovation Fund is the strategic investment arm of the Swiss biopharmaceutical company Debiopharm. With $150 million under management, they recently announced a new seed funding initiative. This initiative aims to support up to 15 seed-stage startups annually. Since its inception in 2006, the fund has invested in 25 companies,… This content is for mem